DL-Demethylcoclaurine CAS NO.5843-65-2

Min.Order: 1 Kilogram
Payment Terms: L/C|T/T|Westem Union||Other

Product Details

Keywords

Quick Details

ProName: DL-Demethylcoclaurine
CasNo: 5843-65-2
Molecular Formula: C16H17NO3
Appearance: off-white powder
Application: They are used primarily in the treatme...
DeliveryTime: as your requirement
PackAge: 1kg/foil bag; 25kg/drum
Port: FOB Shanghai
ProductionCapacity: 10 Metric Ton/Month
Purity: 98%min
Storage: keep in dry cold place
Transportation: BY SEA OR AIR
LimitNum: 1 Kilogram

Superiority

CASNumber: 5843-65-2 Name: 6,7-Isoquinolinediol,1,2,3,4-tetrahydro-1-[(4-hydroxyphenyl)methyl]- SuperlistN…

Details

CAS Number:

5843-65-2

Name:

6,7-Isoquinolinediol,1,2,3,4-tetrahydro-1-[(4-hydroxyphenyl)methyl]-

Superlist Name:

DL-Demethylcoclaurine

Molecular Structure:

Formula:

C₁₆H₁₇NO₃

Molecular Weight:

271.31

Synonyms:

6,7-Isoquinolinediol,1,2,3,4-tetrahydro-1-[(4-hydroxyphenyl)methyl]-, (?à)-;Coclaurine, O-demethyl-, (?à)- (8CI);(RS)-Norcoclaurine;1-(4-hydroxybenzyl)-1,2,3,4-tetrahydroisoquinoline-6,7-diol;(±)-HIGENAMINE;1-(4-Hydroxybenzyl)-1,2,3,4-tetrahydro-6,7-isoquinolinediol;Higenamine;dl-Demethylcoclaurine;6,7-isoquinolinediol, 1,2,3,4-tetrahydro-1-[(4-hydroxyphenyl)methyl]-;6,7-Isoquinolinediol, 1,2,3,4-tetrahydro-1-((4-hydroxyphenyl)methyl)-, (±)-;Isoquinolin-6,7-diol, 1,2,3,4-tetrahydro-1-[4-hydroxybenzyl]-;

Density:

1.317 g/cm³

Boiling Point:

522.4 °C at 760 mmHg

Flash Point:

209.6 °C

【Pharmacological Action】: - Drugs that selectively bind to and activate beta-adrenergic receptors.
- Anti-inflammatory agents that are not steroids. In addition to anti-inflammatory actions, they have analgesic, antipyretic, and platelet-inhibitory actions. They are used primarily in the treatment of chronic arthritic conditions and certain soft tissue disorders associated with pain and inflammation. They act by blocking the synthesis of prostaglandins by inhibiting cyclooxygenase, which converts arachidonic acid to cyclic endoperoxides, precursors of prostaglandins. Inhibition of prostaglandin synthesis accounts for their analgesic, antipyretic, and platelet-inhibitory actions; other mechanisms may contribute to their anti-inflammatory effects. Certain NSAIDs also may inhibit lipoxygenase enzymes or TYPE C PHOSPHOLIPASES or may modulate T-cell function. (AMA Drug Evaluations Annual, 1994, p 1814-5)
- Agents that have a strengthening effect on the heart or that can increase cardiac output. They may be CARDIAC GLYCOSIDES; SYMPATHOMIMETICS; or other drugs. They are used after MYOCARDIAL INFARCT; CARDIAC SURGICAL PROCEDURES; in SHOCK; or in congestive heart failure (HEART FAILURE).
- Fibrinolysin or agents that convert plasminogen to FIBRINOLYSIN.